Merit Medical Systems (MMSI) is back in focus after a recent move in the share price, with the stock closing at US$87.21 and short term returns mixed across different periods.
Over the past year Merit Medical Systems has seen a 10.41% total shareholder return, while the share price momentum has been strongest in the last three months with an 18.75% 90 day share price return. This suggests sentiment has recently improved after a quieter first half of the year.
Scan how Merit Medical Systems compares with other medical stocks showing fresh price momentum by checking the 31 resilient stocks with low risk scores built around resilient balance sheets and steady financial profiles.
After a sharp 90 day climb, Merit Medical Systems now asks a simple question of investors: Is it better to step in at US$87.21 or wait for a cleaner entry based on valuation work.
Most Popular Narrative: 14% Undervalued
On Simply Wall St's narrative, Merit Medical Systems has an estimated fair value of $101.45 compared with the latest close at $87.21, which frames the recent share price move against a valuation gap that still appears open.
Merit Medical Systems is still working through multi year efficiency programs that have already lifted non GAAP operating margin to 22.6% in Q2 2026, with management indicating a total expansion target of about 950 basis points versus 2019. If reached, this could continue to support earnings and free cash flow.
See why 1 investors see Merit Medical Systems as 14% undervalued .
Result: Fair Value of $101.45 (UNDERVALUED)
Still, the story around Merit Medical Systems can change quickly if WRAPSODY CIE reimbursement disappoints, or if tariff costs keep squeezing profitability more than expected.
Find out about the key risks to this Merit Medical Systems narrative .
Next Steps
Mixed signals on Merit Medical Systems often create interesting entry points. Move quickly to test the narrative, weigh the risks against the upside, and review the 3 key rewards and 1 important warning sign .
Looking for more ideas beyond Merit Medical Systems?
Do not stop with Merit Medical Systems. Use the Simply Wall St screener to surface fresh opportunities that fit your style before everyone else starts paying attention.
-
Target resilient cash generators by reviewing the 28 high quality undervalued stocks that pair compressed valuations with solid fundamentals.
-
Build a sturdier core to your portfolio by scanning the list of solid balance sheet and fundamentals (25 results) that can better handle tougher conditions.
-
Hunt for tomorrow's potential standouts early by checking the 20 high quality undiscovered gems that many investors may not be watching yet.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include MMSI .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
